Cipher Pharmaceuticals (CPH) News Today → America’s worst nightmare? (From Porter & Company) (Ad) Free CPH Stock Alerts C$8.69 -0.13 (-1.47%) (As of 05/14/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlines All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative May 15 at 1:56 AM | americanbankingnews.comCipher Pharmaceuticals (TSE:CPH) Stock Rating Lowered by Stifel NicolausMay 13 at 5:58 PM | finance.yahoo.comCipher Pharmaceuticals Downgraded to Hold at Stifel GMP Following Share-Price Gains; Price Target Raised to C$9.50May 13 at 2:51 PM | marketbeat.comCipher Pharmaceuticals (TSE:CPH) Cut to Hold at Stifel NicolausStifel Nicolaus lowered shares of Cipher Pharmaceuticals from a "buy" rating to a "hold" rating and raised their price objective for the company from C$8.00 to C$9.50 in a research report on Monday.May 10, 2024 | marketbeat.comCipher Pharmaceuticals (TSE:CPH) Hits New 1-Year High at $10.33Cipher Pharmaceuticals (TSE:CPH) Reaches New 52-Week High at $10.33May 6, 2024 | marketbeat.comCipher Pharmaceuticals (CPH) Scheduled to Post Quarterly Earnings on ThursdayCipher Pharmaceuticals (TSE:CPH) (NASDAQ:CPHR) will be releasing earnings after the market closes on Thursday, May 9, Zacks reports.April 28, 2024 | theglobeandmail.comCipher Pharmaceuticals: Stocks Overvalued by Analyst Consensus on TSX (CPH)April 27, 2024 | theglobeandmail.comClosing Bell: Cipher Pharmaceuticals Inc flat on Friday (CPH)April 3, 2024 | ca.finance.yahoo.comStocks in play: Cipher PharmaceuticalsApril 1, 2024 | marketbeat.comCipher Pharmaceuticals (TSE:CPH) Shares Down 7.9% Cipher Pharmaceuticals (TSE:CPH) Stock Price Down 7.9%March 28, 2024 | theglobeandmail.comCipher Pharmaceuticals: Top 25 Performing Stocks Year-to-Date on Toronto Stock Exchange (CPH)March 21, 2024 | marketbeat.comCipher Pharmaceuticals (TSE:CPH) Hits New 12-Month High at $9.17Cipher Pharmaceuticals (TSE:CPH) Sets New 12-Month High at $9.17March 17, 2024 | investing.comEarnings call: Cipher Pharmaceuticals outlines growth and financialsMarch 17, 2024 | seekingalpha.comCipher Pharmaceuticals (CPHRF) Q4 2023 Earnings Call TranscriptMarch 15, 2024 | marketbeat.comCipher Pharmaceuticals (TSE:CPH) Hits New 1-Year High After Better-Than-Expected EarningsCipher Pharmaceuticals (TSE:CPH) Hits New 52-Week High Following Strong EarningsMarch 11, 2024 | marketbeat.comCipher Pharmaceuticals (CPH) to Release Earnings on ThursdayCipher Pharmaceuticals (TSE:CPH) (NASDAQ:CPHR) will be releasing earnings after the market closes on Thursday, March 14, Zacks reports.March 6, 2024 | marketbeat.comCipher Pharmaceuticals (TSE:CPH) Share Price Passes Above 50-Day Moving Average of $6.37Cipher Pharmaceuticals (TSE:CPH) Share Price Crosses Above 50-Day Moving Average of $6.37February 14, 2024 | marketbeat.comCipher Pharmaceuticals (TSE:CPH) Stock Passes Above Fifty Day Moving Average of $6.01Cipher Pharmaceuticals (TSE:CPH) Stock Passes Above Fifty Day Moving Average of $6.01February 5, 2024 | marketbeat.comCipher Pharmaceuticals (TSE:CPH) Sets New 1-Year High at $6.67Cipher Pharmaceuticals (TSE:CPH) Reaches New 52-Week High at $6.67January 5, 2024 | morningstar.comCipher Pharmaceuticals Inc CPHJanuary 3, 2024 | finance.yahoo.comCipher Pharmaceuticals Inc (PHE.MU)November 24, 2023 | finance.yahoo.comCipher Pharmaceuticals Announces Change of AuditorNovember 24, 2023 | benzinga.comCipher Pharmaceuticals Stock (OTC:CPHRF) Dividends: History, Yield and DatesNovember 15, 2023 | finance.yahoo.comCipher Pharmaceuticals Inc.'s (TSE:CPH) 23% gain last week benefited both individual investors who own 56% as well as insidersOctober 27, 2023 | finance.yahoo.comCipher Pharmaceuticals Schedules Q3 2023 Earnings Release and Conference CallSeptember 5, 2023 | finance.yahoo.comCipher Pharmaceuticals Announces Intention to Commence Substantial Issuer Bid, Aggregate Price up to $6 Million Canadian DollarsAugust 10, 2023 | finance.yahoo.comCipher Pharmaceuticals Releases Q2 2023 Results, Announces Launch of Epuris in MexicoJuly 28, 2023 | finance.yahoo.comCipher Pharmaceuticals Schedules Q2 2023 Earnings Release and Conference CallJuly 5, 2023 | finance.yahoo.comCipher Partner, Moberg Pharma Announces Approval for MOB-015 in the European UnionJune 21, 2023 | finance.yahoo.comCipher Pharmaceuticals Announces Results of Annual and Special Meeting of ShareholdersMay 4, 2023 | finance.yahoo.comCipher Pharmaceuticals Schedules Q1 2023 Earnings Release and Conference CallApril 26, 2023 | theglobeandmail.comClosing Bell: Cipher Pharmaceuticals Inc flat on Tuesday (CPH)April 20, 2023 | theglobeandmail.comClosing Bell: Cipher Pharmaceuticals Inc flat on Thursday (CPH)April 18, 2023 | finanznachrichten.deBloom Burton & Co. Inc.: Cipher Pharmaceuticals to Present at the 2023 Bloom Burton & Co. Healthcare Investor ConferenceApril 18, 2023 | theglobeandmail.comClosing Bell: Cipher Pharmaceuticals Inc up on Tuesday (CPH)April 18, 2023 | finance.yahoo.comCipher Pharmaceuticals to Present at the 2023 Bloom Burton & Co. Healthcare Investor ConferenceApril 14, 2023 | theglobeandmail.comClosing Bell: Cipher Pharmaceuticals Inc up on Friday (CPH)April 10, 2023 | theglobeandmail.comClosing Bell: Cipher Pharmaceuticals Inc down on Monday (CPH)April 6, 2023 | theglobeandmail.comClosing Bell: Cipher Pharmaceuticals Inc down on Wednesday (CPH)March 19, 2023 | seekingalpha.comCipher Pharmaceuticals Non-GAAP EPS of -$0.12March 16, 2023 | finance.yahoo.comCipher Pharmaceuticals Reports Fourth Quarter and Full Year 2022 Financial ResultsMarch 1, 2023 | finance.yahoo.comCipher Pharmaceuticals Announces Closing of New US$35 Million Credit FacilityDecember 21, 2022 | seekingalpha.comCPH:CA Cipher Pharmaceuticals Inc.December 4, 2022 | finance.yahoo.comCipher Pharmaceuticals Inc.'s (TSE:CPH) Stock Is Going Strong: Have Financials A Role To Play?November 13, 2022 | finance.yahoo.comCipher Pharmaceuticals Third Quarter 2022 Earnings: EPS Beats Expectations, Revenues LagSeptember 14, 2022 | baystreet.caSigna, Boardwalktech, Cipher at 52-Week HighsAugust 5, 2022 | finance.yahoo.comCipher Pharmaceuticals Schedules Q2 2022 Earnings Release and Conference CallJune 22, 2022 | finance.yahoo.comCipher Pharmaceuticals Announces Results of Annual and Special Meeting of Shareholders and Thanks Director Dr. John MullMarch 17, 2022 | finance.yahoo.comCipher Pharmaceuticals Reports Fourth Quarter and Full Year 2021 Financial ResultsNovember 11, 2021 | finance.yahoo.comCipher Announces Third Quarter and Year-to-Date 2021 Financial ResultsNovember 3, 2021 | finance.yahoo.comCipher Pharmaceuticals Schedules Q3 2021 Earnings Release and Conference Call Get Cipher Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for CPH and its competitors with MarketBeat's FREE daily newsletter. Email Address With revenue forecasted to grow dramatically in 2024 and beyond, this company should be on your radar (Ad)Revolutionizing communication is what this NASDAQ-traded next-gen solution provider is doing. See how this company is well-positioned to capitalize in 2024 CPH Media Mentions By Week CPH Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. CPH News Sentiment▼0.420.56▲Average Medical News Sentiment CPH News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. CPH Articles This Week▼60▲CPH Articles Average Week Get Cipher Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for CPH and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: OGI News CRDL News HLS News RX News ACB News GUD News QIPT News HTL News MDNA News DR News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (TSE:CPH) was last updated on 5/15/2024 by MarketBeat.com Staff From Our PartnersTech GIANT’s Plans to Revolutionize Crypto…Crypto 101 MediaThe 2024 Gold Rush: Unleashing Market PotentialPriority GoldWith revenue forecasted to grow dramatically in 2024 and beyond, this company should be on your radarStocks NewsCEO of Biggest AI Chipmaker Just Dropped a Bombshell…Banyan Hill PublishingGold Set to EXPLODE!Gold Safe ExchangeExposed: 10 CENT Crypto to Explode May 20th?True Market InsidersCharles Payne Demystifies OptionsUnstoppable ProsperityThe A.I. story nobody is telling you (Read ASAP)TradeSmith Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cipher Pharmaceuticals Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
